<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">The clinical manifestations of the 160 cases included blurred vision (53.75%, 86/160, 95%
 <italic>CI</italic>: 45.94–61.60), conjunctival follicles (85.00%, 136/160, 95%
 <italic>CI</italic>: 79.41–90.59), photophobia (61.88%, 99/160, 95%
 <italic>CI</italic>: 54.27–69.48), conjunctival congestion (60.00%, 96/160, 95%
 <italic>CI</italic>: 52.33–67.67), periorbital swelling (51.89%, 83/160 95%
 <italic>CI</italic>: 44.05–59.70), eye discharge (46.25%, 74/160, 95%
 <italic>CI</italic>: 38.44–54.06), red eyes (43.13%, 69/160, 95%
 <italic>CI</italic>: 35.37–50.88), ophthalmodynia (38.75%, 62/160, 95%
 <italic>CI</italic>: 31.12–46.38), tearing (36.88%, 59/160, 95%
 <italic>CI</italic>: 29.32–44.43), pseudomembranes (22.50%, 36/160, 95%
 <italic>CI</italic>: 15.96–29.04), foreign body sensation (21.88%, 35/160, 95%
 <italic>CI</italic>: 15.40–28.35), eye itch (21.88%, 35/160, 95%
 <italic>CI</italic>: 15.40–28.35), preauricular lymph node enlargement (14.38%, 23/160, 95%
 <italic>CI</italic>: 8.88–19.87), and corneal epithelial infiltration (6.25%, 10/160, 95%
 <italic>CI</italic>: 2.46–10.04).
</p>
